Extended Data Fig. 5: The ER−/HER2− integrative subtypes exhibit distinct risks of relapse.
From: Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
The probabilities of distant relapse or cancer-related death among ER−/HER2− patients who were disease-free at five years after diagnosis reveal marked differences in the risk of relapse for TNBC IntClust subtype IC4ER− versus the IC10 (basal-like enriched) subtype. Here the base clinical model with IHC subtypes is compared with the base clinical model plus IntClust subtype information. Error bars represent 95% confidence intervals. The number of patients in each group is indicated.
